Mirati Therapeutics reported $0 in Debt for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Acceleron Pharma XLRN:US $ 0M 0M
Agios Pharmaceuticals AGIO:US $ 0.41M 0.59M
Alnylam Pharmaceuticals ALNY:US $ 433.8M 0.65M
Amgen AMGN:US $ 37579M 4797M
Astellas Pharma 4503:JP Y 310955M 37900M
AstraZeneca AZN:LN 31912M 4417M
Bayer BAYN:GR € 41766M 1394M
Biocryst Pharmaceuticals BCRX:US $ 304.16M 10.51M
Bluebird Bio BLUE:US $ 0M 0M
Bristol Myers Squibb BMY:US $ 44742M 416M
Eisai 4523:JP Y 89912M 2771M
Eli Lilly And LLY:US $ 17085.4M 570.3M
Exelixis EXEL:US $ 0M 0M
GlaxoSmithKline GSK:LN 25605M 122M
IONIS PHARMACEUT IONS:US $ 1303M 7.54M
Moderna Inc MRNA:US 456M 31M
Nektar Therapeutics NKTR:US $ 0M 0M
Novartis NOVN:VX SF 34243M 1526M
Puma Biotechnology PBYI:US $ 96.8M 3.33M
Sarepta Therapeutics SRPT:US $ 1094.91M 1.93M
Seattle Genetics SGEN:US $ 0M 0M
Spectrum Pharmaceuticals SPPI:US $ 0M 0M
Takeda 4502:JP Y 4231359M 174502M
Ultragenyx Pharmaceutical RARE:US $ 0M 0M
YTE INCY:US $ 33.78M 0.47M